When symptom trends group together, act on them using a set plan: hold, step back, or ask for a provider's review
To view a copy of this license, visit About this article Cite this article Pinto, L.C., Falcetta, M.R., Rados, D.V
In the SURMOUNT-1 trial, tirzepatide at the highest dose (15 mg) produced average weight loss of 22.5% versus approximately 15% for semaglutide in comparable trials
However, the scientific evidence supporting their use in healthy adults remains limited, with most data derived from preclinical studies, small clinical trials in specific populations (e.g., sarcopenia or HIV-associated wasting), or off-label applications
Body contouring after weight loss with GLP-1 medications Patients also come to us for excess skin removal after losing weight with prescription weight loss injections